Showing 361 - 380 of 2732 results
A large international collaboration has developed a straightforward and cost-effective synthesizing approach using a 3D printing technique to produce single atom catalysts (SACs)—potentially paving the way for large scale commercial production with broad industrial applications.
ANSTO is working with government partners to ensure that radioactivity in drinking water supplied to Aboriginal communities is at levels considered safe for consumption.
ANSTO health researchers have contributed to an international study published in Nature Neuroscience that sheds light on the mechanism by which anti-anxiety drugs act on the brain which could lead to cognitive impairment in vulnerable individuals.
A world-first processing technology developed in collaboration by ANSTO’s Minerals unit.
International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.
ANSTO is dedicated to identifying opportunities for the application of knowledge and technology developed by the organisation for a wide range of industry applications.
The Think Science! event encourages students to engage with the Science Inquiry Skills process as outlined in the Australian National Curriculum.
ANSTO has played a formative role and continues to make important contributions using nuclear and isotopic techniques to understand past climates and patterns of change, maintain water resource sustainability and provide insights into the impact of contaminate in the environment.
Three ANSTO scientists are contributing to two recently awarded Australian Research Council Discovery Project grants.
The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.
Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron neutron capture therapy, a promising radiation therapy for treating aggressive cancers.